Related references
Note: Only part of the references are listed.Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice
Erica L. Clinkenbeard et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
High Dietary Phosphate Intake Induces Development of Ectopic Calcifications in a Murine Model of Familial Tumoral Calcinosis
Shoji Ichikawa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing
Anuja Shah et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Dysregulated Gene Expression in the Primary Osteoblasts and Osteocytes Isolated from Hypophosphatemic Hyp Mice
Kazuaki Miyagawa et al.
PLOS ONE (2014)
Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23
Zhousheng Xiao et al.
PLOS ONE (2014)
Hereditary Deletion of the Entire FAM20C Gene in a Patient With Raine Syndrome
Farouq K. Ababneh et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Fibroblast Growth Factor 23 and Klotho Are Present in the Growth Plate
Adalbert Raimann et al.
CONNECTIVE TISSUE RESEARCH (2013)
Nuclear Fibroblast Growth Factor 2 (FGF2) Isoforms Inhibit Bone Marrow Stromal Cell Mineralization Through FGF23/FGFR/MAPK In Vitro
Liping Xiao et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells
Shoji Ichikawa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
Yves Sabbagh et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Circulating αKlotho influences phosphate handling by controlling FGF23 production
Rosamund C. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice
Xiaofang Wang et al.
PLOS GENETICS (2012)
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
Yumie Rhee et al.
BONE (2011)
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
Emily G. Farrow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Loss-of-Function ENPP1 Mutations Cause Both Generalized Arterial Calcification of Infancy and Autosomal-Recessive Hypophosphatemic Rickets
Bettina Lorenz-Depiereux et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Increased Bone Volume and Correction of HYP Mouse Hypophosphatemia in the Klotho/HYP Mouse
Catherine A. Brownstein et al.
ENDOCRINOLOGY (2010)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation
Emily G. Farrow et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Ablation of the Galnt3 Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite Increased Fgf23 Expression
Shoji Ichikawa et al.
ENDOCRINOLOGY (2009)
Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral Calcinosis
Clemens Bergwitz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis
Holly J. Garringer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice
Shiguang Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Shoji Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets
Erik A. Imel et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice
Martina Hesse et al.
MATRIX BIOLOGY (2007)
Correlation between hyperphosphatemia and type IINa-Pi cotransporter activity in klotho mice
Hiroko Segawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis
Bettina Lorenz-Depiereux et al.
NATURE GENETICS (2006)
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism
Jian Q. Feng et al.
NATURE GENETICS (2006)
The role of mutant UDP-N-acetyl-α-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis
Holly J. Garringer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Pathogenic role of Fgf23 in Hyp mice
Shiguang Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: Frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23
KE White et al.
ENDOCRINE REVIEWS (2006)
Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D
Shiguang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Regulation of fibroblast growth factor-23 signaling by Klotho
H Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice
F Perwad et al.
ENDOCRINOLOGY (2005)
Dentin matrix protein 1 gene cis-regulation -: Use in osteocytes to characterize local responses to mechanical loading in vitro and in vivo
WC Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis
T Larsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
A Benet-Pagès et al.
HUMAN MOLECULAR GENETICS (2005)
Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders
Y Frishberg et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa
T Shimada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues
F Liu et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
T Larsson et al.
ENDOCRINOLOGY (2004)
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
D Sitara et al.
MATRIX BIOLOGY (2004)
Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis
O Topaz et al.
NATURE GENETICS (2004)
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
SG Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
KB Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene
Martin Holzenberger et al.
NUCLEIC ACIDS RESEARCH (2000)
Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain
T Yamashita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
